News Focus
News Focus
icon url

DewDiligence

04/22/19 10:20 AM

#224736 RE: DewDiligence #223592

FDA approves Ketyruda/Inlyta in 1L-RCC:

https://finance.yahoo.com/news/fda-approves-merck-keytruda-pembrolizumab-104500869.html

The RCC battle lines are set: Opdivo/Yervoy vs Keytruda/Inlyta.